Infection following shoulder arthroplasty is a rare but devastating complication. The rate of prosthetic joint infection (PJI) varies between 0.6% and 1.46%[@B1], [@B2]. The diagnosis of PJI in patients with shoulder arthroplasty is challenging. The diagnosis is established using a combination of clinical findings and laboratory studies[@B3]. Among these, analysis of synovial fluid cell count is a valuable adjunctive test for establishing the diagnosis of PJI[@B4], [@B5]. The optimal cut-off of synovial fluid leukocyte count and differential of polymorphonuclear leukocytes (PMN) is dependent on the duration of the joint life, site of the prosthesis, and presence of other comorbid conditions[@B3]. We herein present a study assessing the utility of synovial fluid cell count and differential in the diagnosis of patients with suspected shoulder PJI.

The Cantonal Hospital St. Gallen serves as a tertiary care centre for orthopaedic and trauma surgery in Switzerland. In patients with painful shoulder arthroplasties and planned revision surgery, we routinely perform pre-operative joint aspiration of synovial fluid assessing cell count, differential cell analysis, crystals and microbiological culture incubated for 14 days. Cell counts are performed by automated counting (Sysmex XN-1000, Sysmex Suisse AG, Horgen, Switzerland). In this study, we analysed the results of consecutive patients who underwent joint aspirations from April 2011 to June 2018. PJI was defined according the previously published IDSA criteria[@B5]. Due to a reported low specificity in the early postoperative phase, only joint aspirations performed \> 6 weeks after surgical intervention (i.e.; implantation or revision) were included in this study[@B6]. Informed consent was obtained from all patients enrolled in this study.

During the study period, 39 joint aspirations in patients with symptomatic shoulder arthroplasties were performed. Of these, 20 were excluded (3 punctures within six weeks of last surgical intervention, 11 cases with dry tap, 5 cases with microbiologic cultures \[without cell count analyses\], and in one case the results were inconclusive). Hence, the analysis included 19. In 16 of them, a leukocyte differential analysis was also performed. 13 cases met the PJI definition and six cases were classified as non-PJI.

The isolated organisms in monomicrobial infections included *Cutibacterium acnes* (5 cases), coagulase-negative staphylococci (3 cases), *Staphylococcus aureus*, *Streptococcus anginosus* and *Finegoldia magna* (one case each). Two patients had polymicrobial infections (table [1](#T1){ref-type="table"}). Cell count in shoulder PJI ranged between 3.7 to 218.5 G/L, and the percent of PMNs ranged between 74% to 99%; In non-PJI cases the same ranged from \<0.1 to 6.8 G/L, and from 9 to 91% respectively. One patient in the non-PJI group had a high cell count and differential (6.8 G/L and 91% PMN). In this case, foreign body reaction with polyethylene particles was documented on histologic examination of peri-prosthetic tissue. In the other 5 non-PJI cases, the cell count varied between \<0.1 to 3.1 G/L, and the PMNs percentage from 9 to 33%. The 2 patients diagnosed with polymicrobial infections had high cell counts (\>100 G/L).

To assess the optimal sensitivity and specificity of synovial fluid leukocyte count and PMN for differentiating aseptic failure from PJI, ROC curves were performed (figure [1](#F1){ref-type="fig"}). The area under the ROC curve was 0.987 for leukocyte count and 0.854 for PMN differential count. Optimal cut-off values for the 19 cases was 12.2 G/L for leukocyte counts (sensitivity 92% and specificity 100%) and 54% for PMN differential (sensitivity 100% and specificity 75%) (figure [1](#F1){ref-type="fig"}).

Preoperative shoulder joint fluid aspiration assessing cell count and culture is a helpful diagnostic tool for establishing the diagnosis of PJI and - in culture positive cases - for guiding the choice of antimicrobial management in patients with hip and knee PJI[@B7]. In a recent meta-analysis, cut-off values ranged from 2.5 to 5 G/L and 60-89% for PMNs differential in total knee arthroplasty and total hip arthroplasty (THA)[@B8]. The results of this study support the hypothesis that cut-off values for hip or knee PJI cannot be extrapolated to other joints[@B5], [@B9]. The size of the joint, the surrounding synovial volume, the soft-tissue mantle, and the vascularization may influence the cut-offs of cell counts and differential in the diagnosis of PJI[@B9], [@B10]. On the basis of these arguments, it is conceivable that optimal cut-off values for shoulder PJI has not yet been optimally defined. To the best of our knowledge, only two studies have investigated the accuracy of synovial cell count in shoulder PJI. Piper et al.[@B11] analysed 28 patients (18 aseptic failure, 10 shoulder PJI) and used proposed cut-off values for knee PJI (\>1.7 G/L and 65% PMN). Only 5 (50%) patients with confirmed PJI met the cell-count count criterion, and 7 (70%) that for PMN[@B11]. Jerosch et al.[@B12] analysed 12 patients and suggested that a cell count above 30 G/L was suggestive for shoulder PJI. In the series published by Renz et al.[@B13], synovial fluid leukocyte count was available only for one patient with shoulder PJI. Infection was caused by *C. acnes* and synovial fluid analysis revealed a high cell count (\>80 G/L) and differential (\> 90 %PMN). Our study includes 19 aspirates (6 aseptic failures, 13 shoulder PJI), and all cases with infection had values ≥3.7 G/L and ≥74% PMN. In contrast, only one case with aseptic loosening had a high cell count (case 7, table [1](#T1){ref-type="table"}) likely due to a foreign body reaction. All three investigations have similar limitations, including a small sample size (28, 12 and 19 cases, respectively) and inherent limitations related to single-centre and retrospective study design. Nonetheless, they suggest that the cut-off used for synovial leukocyte value for establishing the diagnosis of shoulder PJI is higher than the ones described for knee or hip PJI[@B8], [@B12]-[@B15].

Cell count is an immune response associated with the microbial virulence of the infecting agent. One could hypothesize that in shoulder PJI, cell-counts are insensitive for diagnosis because low-grade microorganisms are commonly encountered in shoulder PJI[@B3], [@B11], [@B14]. The results of our study do not support this hypothesis. Low-grade infection organisms were associated with the presence of a high cell-count (table [1](#T1){ref-type="table"}).

Of note, in 11 (28%) of 39 cases, there was a dry tap. Synovial fluid aspiration from the shoulder joint is more challenging than the ones from knee joints. This may support the hypothesis that not all diagnostic concepts can be extrapolated from the knee joint to the shoulder joint.

In conclusion, synovial fluid aspiration in shoulder arthroplasty is a helpful preoperative diagnostic method in establishing the diagnosis of PJI. However, a high frequency of dry tap was observed. We found no indications that low-virulent organisms are associated with a low cell count in shoulder PJI. Our results and that of others[@B12], [@B13], indicate that the optimal synovial leukocyte and polymorphonuclear cell count cut-off for shoulder PJI is higher than the ones described for knee or hip PJI. Additional multi-centre studies are warranted to confirm those findings.
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PJI

:   prosthetic joint infection

PMN

:   polymorphonuclear leukocytes.
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###### 

Cell counts and differential PMN, culture results of 19 aspirates.

  Cell count \[G/L\]   %PMN   Infection   Cultures            Interval from implantation   Revision arthroplasty?   Interval from last surgery (if not arthroplasty)
  -------------------- ------ ----------- ------------------- ---------------------------- ------------------------ --------------------------------------------------
  0.00                 n/a    no          negative            1.6 years                    no                       
  0.38                 33%    no          negative            2.2 years                    yes                      
  0.70                 9%     no          negative            2.2 years                    no                       
  3.06                 n/a    no          negative            1.3 years                    no                       
  3.10                 7%     no          negative            3.8 years                    no                       
  3.71                 74%    yes         *C. acnes*          167 days                     no                       
  6.83                 91%    no          negative            3 years                      no                       
  17.51                95%    yes         CNS                 2.2 years                    yes                      
  22.30                84%    yes         *C. acnes*          50 days                      yes                      
  36.50                95%    yes         *C. acnes*          3.4 years                    no                       
  37.40                80%    yes         *F. magna*          1.1 years                    no                       
  42.50                90%    yes         CNS                 5 years                      yes                      
  46.35                92%    yes         CNS                 2 years                      no                       315 days
  54.67                88%    yes         *S. anginosus*      105 days                     yes                      
  74.39                n/a    yes         *C. acnes*          1.3 years                    no                       
  119.62               99%    yes         *C. acnes* / CNS    7.8 years                    no                       77 days
  164.00               82%    yes         *Staph aureus*      273 days                     no                       
  176.95               94%    yes         *C. acnes*          10.2 years                   no                       
  218.50               89%    yes         *C. avidum* / CNS   2.5 years                    no                       

Time interval from arthroplasty in years or days (when less than one year). When last revision was not the arthroplasty (2 patients), interval from last revision to puncture was specified separately (column "Interval from last surgery (if not arthroplasty)"). When puncture was performed in a revision arthroplasty (i.e. conversion from anatomic to inverse shoulder arthroplasty), this was specified in a separate column "Revision arthroplasty?".

CNS coagulase-negative staphylococcus; PMN polymorphonuclear leukocytes; n/a not available
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